Two studies published in the New England Journal of Medicine "equip us with strategies to deal with the current imperfections in our scale-up efforts" to prevent mother-to-child transmission of HIV, write Marc Lallemant and Gonzague Jourdain of the Harvard School of Public Health in a New England Journal of Medicine editorial. The editorial compares the findings with updated WHO guidelines on PMTCT. The editorial also looks at questions that arise given the findings including: the difference in long-term response to the two drugs, strategies for preserving or "recycling" nevirapine therapy and the higher cost of ritonavir-boosted lopinavir compared with nevirapine (10/14).
Back to other news for October 2010
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy